Login
$LSTA
$1.10 +$0.01 (0.92%) After hours

Company Executives

Officer Age In this role 2025 pay Source
David J. Mazzo Also a director
Chief Executive Officer
69 Not stated $1,147,359
Josh Lehrer
President and Chief Operating Officer
53 Since 2026
this year
Not reported
James Nisco
Senior Vice President Finance and Treasury and Chief Accounting Officer
56 Since 2024
2 years
$433,464
Tariq Imam
Senior Vice President, Business Development and Operations and General Counsel
44 Since 2025
1 year
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
5 of 5
stated in the proxy; 3 not stated
Average tenure
6.1 years
from year joined
CEO also chairs the board
No
Gregory B. Brown, M.D.
Director Age On board Independent Other public boards 2025 pay Source
Gregory B. Brown, M.D.
72 2016
10 years
Independent Aquestive Therapeutics $154,500
David J. Mazzo, Ph.D.
69 2015
11 years
Not stated None stated Paid as CEO
Cynthia L. Flowers
66 2018
8 years
Independent Hikma Pharmaceuticals PLC $112,500
Ted W. Love
67 2026
this year
Independent Jazz Pharmaceutics plc, Gilead Sciences, Inc., Royalty Pharma plc, Structure Therapeutics Inc. Not stated
Heidi Henson
60 2022
4 years
Independent PepGen Inc., Perspective Therapeutics , Inc. $124,000
Mohammad Azab, M.D., M.B.A.
70 2022
4 years
Not stated DURECT Corporation $113,500
Steven M. Klosk, J.D.
69 2014
12 years
Not stated None stated $120,000
Jeffrey Farrow
65 2026
this year
Independent Clover Biopharmaceuticals, Ltd., Achieve Life Sciences, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Oct 19, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support